Anti‐Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU‐145) Cells: In‐Vitro Study
IET Nanobiotechnology · 2024
DOI: 10.1049/2024/8929168 ↗Kurz gefasst
Fachartikel in der Zeitschrift IET Nanobiotechnology, 2024. Verfasst von Nazanin Oroskhani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cobalt, Prostatic Neoplasms, Poloxamer, Ferric Compounds. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran University of Medical Sciences.
Abstract (Originalsprache)
Prostate cancer is the second most frequent type of cancer death in men. This study refers to the novel hyperthermia application of poloxamer‐coated cobalt ferrite as a new approach for thermal eradication of DU‐145 human prostate cancerous cells under a radio frequency magnetic field (RF‐MF). The hydrothermal method was applied for the synthesis of cobalt ferrite nanoparticles. Then, the structure, size, and morphology of nanoparticle were characterized. The cytotoxicity of the synthesized nanoparticles and RF‐MF exposure on DU‐145 prostate cancer cells was investigated separately or in combination with colony formation methods and MTT [3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide] assay. Transmission electron microscopy (TEM) confirmed the spherical morphology of nanoparticles with a size of 5.5 ± 2.6 nm. The temperature of cells treated with nanoparticles under RF‐MF reached 42.73 ± 0.2°C after 15 min. RF‐MF treatment or nanoparticles have not affected cell viability significantly. However, the combination of them eradicated 53% ± 4% of cancerous cells. In‐vitro hyperthermia was performed on human prostate cancer cells (DU‐145) with cobalt ferrite nanoparticles at specific concentrations that demonstrated a decrease in survival fraction based on colony formation assay compared to cells that were treated alone with nanoparticles or with RF‐MF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Finetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Materials Science and Engineering, K. N. Toosi University of Technology, Tehran, Iran.
ORCID-Profile: Seyed Mohammad Amini, Sakine Shirvalilou, Mehdi Khodaie, Seyed Rabi Mahdavi
Förderung
- Iran University of Medical Sciences
Zitieren
APA
Oroskhani, N., Amini, S. M., Shirvalilou, S., Khodaie, M., & Mahdavi, S. R. (2024). Anti‐Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU‐145) Cells: In‐Vitro Study. IET Nanobiotechnology. https://doi.org/10.1049/2024/8929168
Vancouver
Oroskhani N, Amini SM, Shirvalilou S, Khodaie M, Mahdavi SR. Anti‐Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU‐145) Cells: In‐Vitro Study. IET Nanobiotechnology. 2024. doi:10.1049/2024/8929168
BibTeX
@article{Oroskhani2024,
author = {Oroskhani, Nazanin and Amini, Seyed Mohammad and Shirvalilou, Sakine and Khodaie, Mehdi and Mahdavi, Seyed Rabi},
title = {Anti‐Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU‐145) Cells: In‐Vitro Study},
journal = {IET Nanobiotechnology},
year = {2024},
doi = {10.1049/2024/8929168}
}
EUVIMED